Dr. Sugarman conducts both theoretical and empirical research in medical ethics. His work concentrates on informed consent, research ethics, and the ethical issues associated with emerging technologies. He is the author of over 175 publications in peer-reviewed journals. He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; and Methods in Medical Ethics). Dr. Sugarman is an associate editor of Clinical Trials, a contributing editor for IRB, and is on the editorial boards of Accountability in Research and Theoretical Medicine and Bioethics. Dr. Sugarman serves on the Scientific and Research Advisory Board for the Canadian Blood Service and is a member of the Maryland Stem Cell Research Commission. He is currently Chair for the Ethics Working Group of the HIV Prevention Trials Network, the Ethics Officer for the Resuscitation Outcomes Consortium, and Co-Chair of the Johns Hopkins’ Embryonic Stem Cell Research Oversight Committee.

Ethics; Medical Ethics; Bioethics; Research Ethics

Dr Sugarman is a Fellow of the American Association for the Advancement of Science, the American College of Physicians, and the Hastings Center.

Lavori P, Wilt T, Sugarman J. Quality assurance questionnaire for professionals fails to improve the quality of informed consent. Clin Trials 2007; 4: 638-649.

Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh A, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, Meslin EM, Murphy J, Nussbaum RL, Otlowski M, Pullman D, Ray P N, Sugarman J, Timmons M. Research ethics recommendations for whole-genome research: consensus statement. PLoS Biology. 2008 March;6:430-435.

Weinfurt KP, Hall MA, Dinan MA, DePuy V, Friedman JY, Allsbrook JS, Sugarman J. Effects of disclosing financial interests on attitudes toward clinical research. J Gen Intern Med 2008; 23:860-6.

Mathews DJ, Sugarman J, Bok H, Blass DM, Coyle JT, Duggan P, Finkel J, Greely HT, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Regenberg A, Siegel AW, Smith K, Solter D, Song H, Vescovi A, Young W, Gearhart JD, Faden R. Cell-based interventions for neurologic conditions: Ethical challenges for early human trials. Neurology 2008; 71: 1-6.

Kass N, Pronovost PJ, Sugarman J, Goeschel CA, Lubomski LH, FadenR. Controversy and quality improvement: lingering questions about ethics, oversight and patient safety research. The Joint Commission J on Quality and Patient Safety 2008;34: 349-353.

Participants in the 2006 Georgetown University Workshop on the Ancillary-Care Obligations of Medical Researchers Working in Developing Countries (Sugarman J). The ancillary-care obligations of medical researchers working in developing countries. PLOS Medicine 2008; 5: 709-713.

Koniaris LG, Goodman KW, Sugarman J, Ozomaro U, Sheldon J, Zimmers TA. Ethical implications of modifying lethal injection protocols. PLOS Medicine 2008; 5 (6), e126 doi:10.1371/journal. pmed.0050126.

Sugarman J, Bingham CO. Ethical issues in rheumatology trials. Nature Clin Pract Rheum 2008; 4:356-363.

Sugarman J. Human stem cell ethics: beyond the embryo. Cell Stem Cell 2008; 2:529-533.

Taylor HA, Chaisson L, Sugarman J. Enhancing communication among data monitoring committees and institutional review boards. Clinical Trials 2008; 5;277-282.

McCullough J, Kahn J, Adamson J, Anderlini P, Benjamin R, Confer D, Eapen M, Hirsch B, Kuter D, Lazarus E, Pamphilon D, Stronek D, Sugarman J, Wilson R. Hematopoietic growth factors – use in normal blood and stem cell donors: clinical and ethical issues: summary of a conference. Transfusion 2008; 48:2008-25.

Weinfurt KP, Hall MA, Friedman JY, Hardy C, Fortune-Greeley AK, Lawlor JS, Allsbrook JS, Lin L, Schulman KA, Sugarman J. Effects of disclosing financial interests on participation in medical research: a randomized vignette trial. Am Heart J 2008: 156:689-697.

Karp DR, Carlin S, Cook-Deegan R, Ford DE, Geller G, Glass DN, Greely H, Guthridge J, Kahn J, Kaslow R, Kraft C, MacQueen K, Malin B, Scheuerman RH, Sugarman J. Ethical and practical Issues associated with aggregating databases. PLoS Medicine 2008; 5: e190 doi:10.1371/journal.pmed.0050190.

Tisherman SA, Powell JL, Schmidt TA, Auferheide TP, Kudenchuk PJ, Spence J, Climer D, Kelly D, Marcantonio A, Brown T, Sopko G, Kerber R, Sugarman J, Hoyt D and the ROC Investigators. Regulatory challenges for the Resuscitation Outcomes Consortium. Circulation 2008; 118: 1585-1592.

Crump J, Sugarman J. Ethical considerations for short-term experiences by trainees in global health. JAMA 2008; 300: 1456-1458.

Kass N, Taylor H, Fogarty L, Sugarman J, Goodman SN, Goodwin-Landher A, Carducci M, Hurwitz H. Purpose and benefits of early phase cancer trials: What do oncologists say? What do patients hear? J Empirical Research on Human Research Ethics 2008; DOI 10.1525/jer.2008.3.3.57.

Sugarman J, Siegel A. How to determine whether existing human embryonic stem cell lines can be used ethically. Cell Stem Cell 2008; 3:3;238-9. Sugarman J, Siegel AW. When embryonic stem cell lines fail to meet consent standards. Science 2008; 322: 379. Czarny MJ, Faden RR, Nolan MT, Bodensiek E, Sugarman J. Medical and nursing students’ television viewing habits: potential implications for bioethics. Am J Bioethics 2008 8:1-8.

Hyun I, Lindvall O, Ahrlund-Richter L, Cattaneo E, Cavazzana-Calvo M, Cossu G, De Luca M, Fox IJ, Gerstle C, Goldstein RA, Hermeren G, High KA, Kim HO, Lee HP, Levy-Lahad E, Li L, Lo B, Marshak DR, McNab A, Munsie M, Nakauchi H, Rao M, Rooke HM, Valles CS, Srivastava A, Sugarman J, Taylor PL, Veiga A, Wong AL, Zoloth L, Daley GQ. New ISSCR Guidelines underscore major principles for responsible translational stem cell research. Cell Stem Cell 2008; 3:607-609.

Lyerly AD, Steinhauser K, Voils C, Namey E, Alexander C, Bankowski B, Cook-Deegan R, Dodson WC, Gates E, Jungheim ES, McGovern PG, Myers ER, Osborn B, Schlaff W, Sugarman J, Tulsky JA, Walmer D, Faden RR, Wallach E. Fertility patients’ views about frozen embryo disposition: results of a multi-institutional U.S. survey. Fertil Steril 2008; Dec 2 [Epub ahead of print].

Hull SC, Sharp RR. Botkin JR, Brown M, Hughes M, Sugarman J, Schwinn D. Sankar P, Bolcic-Jankovic D, Clarridge BR, Wilfond BS.Patients' views on identifiability of samples and informed consent for genetic research. Am J Bioethics 2008; 8:62-70.

Regenberg A, Mathews DJH, Blass DM, Bok H, Coyle JT, Duggan P, Faden R, Finkel J, Gearhart JD, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, King P, Kurtzberg J, Liao SM, McDonald JW, McKhann G, Nelson KB, Rao M, Siegel AW, Smith K, Solter D, Song H, Sugarman J, Vescovi A, Young W, Greely HT, Traystman RJ. The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions. J Cerebral Blood Flow & Metabolism 2009; 20:1-9.

Hall MA, Weinfurt KP, Lawlor JS, Friedman JY, Schulman KA, Sugarman J. Community hospital oversight of clinical investigators’ financial relationships. IRB 2009; 31:7-13.

Sugarman J. Commentary: A call for preventive ethics. [Commentary] BMJ 2009;338:b753.

Sugarman J, Sitlani C, Andrusiek D, Auferheide T, Bulger EM, Davis DP, Hoyt DB, Idris A, Kerby JD, Powell J, Schmidt T, Slutsky AS, Sopko G, Stephens S, Williams C, Nichol G, and the Resuscitation Outcomes Consortium Investigators. Resuscitation 2009; 80: 644-649.

Duggan PS, Siegel AW, Blass DM, Bok H, Coyle JT, Faden R, Finkel J, Gearhart JD, Greeely HT, Hillis A, Hoke A, Johnson R, Johnston M, Kahn J, Kerr D, King P, Kurtzberg J, Liao SM, McDonald JW, McKahn G, Nelson KB, Rao M, Regenberg A, Smith K, Solter D, Song H, Sugarman J, Traystman RJ, Vescovi A, Yanofski J, Young W, Mathews DJH. Unintended changes in cognition, mood, and behavior arising from cell-basd interventions for neurological conditions: ethical challenges. Am J Bioethics 2009; 9: 31-36.

Kass NE, Sugarman J, Medley AM, Fogarty LA, Taylor HA, Daugherty CK, Emerson MR, Goodman SN, Hlubocky FJ, Hurwitz HI, Carducci M, Goodwin-Landher A. An intervention to improve cancer patients’ understanding of early-phase clinical trials. IRB 2009; 31: 1-10.